Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin is significantly associated with survival of intubated COVID-19 patients
Vijendra Ramlall, Jason Zucker, Nicholas P. Tatonetti
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 173
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
Robert Root‐Bernstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 98
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi‐Perumal
Diseases (2020) Vol. 8, Iss. 4, pp. 44-44
Open Access | Times Cited: 79
Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial
Seyed Abbas Mousavi, Keyvan Heydari, Hossein Mehravaran, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 263-271
Open Access | Times Cited: 75
Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc
Salvatore Corrao, Raffaella Mallaci Bocchio, Marika Lo Monaco, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1261-1261
Open Access | Times Cited: 62
Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review
Tianbao Li, Tao Huang, Cheng Guo, et al.
The Innovation (2021) Vol. 2, Iss. 2, pp. 100116-100116
Open Access | Times Cited: 57
Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases
Rüssel J. Reiter, Ramaswamy Sharma, Sergio Rosales‐Corral
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 764-764
Open Access | Times Cited: 53
Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology
George Anderson, Annalucia Carbone, Gianluigi Mazzoccoli
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1597-1597
Open Access | Times Cited: 48
Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
Adam Wichniak, Aleksander Kania, Mariusz Siemiński, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8623-8623
Open Access | Times Cited: 44
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Rüssel J. Reiter, Ramaswamy Sharma, Fedor Šimko, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 35
Efficacy of melatonin in the treatment of patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials
Shao‐Huan Lan, Hong‐Zin Lee, Chien‐Ming Chao, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2102-2107
Open Access | Times Cited: 34
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Dun‐Xian Tan, Rüssel J. Reiter
Life Sciences (2022) Vol. 294, pp. 120368-120368
Open Access | Times Cited: 30
Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond
Mark F. McCarty, Simon Bernard Iloki Assanga, Lidianys María Lewis Luján, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 47-47
Open Access | Times Cited: 45
Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine
Kneginja Richter, Stefanie Kellner, Thomas Hillemacher, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 221-241
Open Access | Times Cited: 38
Sleep in Older Adults and Its Possible Relations With COVID-19
Gabriel Natan Pires, Isabela A. Ishikura, Sandra Doria Xavier, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 35
Role of Melatonin on Virus-Induced Neuropathogenesis—A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection
Prapimpun Wongchitrat, Mayuri Shukla, Ramaswamy Sharma, et al.
Antioxidants (2021) Vol. 10, Iss. 1, pp. 47-47
Open Access | Times Cited: 31
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
Eva Ramos, Francisco López‐Muñoz, Emilio Gil‐Martín, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1152-1152
Open Access | Times Cited: 24
Melatonin, Zinc, and Vitamin C: Potential Adjuvant Treatment for COVID-19 Patients
Leandro Borges, Matheus Gennari-Felipe, Beatriz Belmiro Dias, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 18
The role of melatonin as an adjuvant in the treatment of COVID-19: A systematic review
Arezoo Faridzadeh, Arefeh Tabashiri, Hamid Heidarian Miri, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10906-e10906
Open Access | Times Cited: 18
Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment
Giou‐Teng Yiang, Chia‐Chao Wu, Chien‐Lin Lu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 156-156
Open Access | Times Cited: 10
Evaluation of the effect of melatonin on patients with COVID-19 admitted to ICU: A double-blind randomized clinical trial
Mahmoud Ganjifard, Shokouh Ghafari, Adeleh Sahebnasagh, et al.
Vacunas (English Edition) (2025) Vol. 26, Iss. 1, pp. 100377-100377
Closed Access
Melatonin as an Add-On Treatment of COVID-19 Infection: Current Status
Gregory M. Brown, Seithikurippu R. Pandi‐Perumal, Harold Pupko, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 64-64
Open Access | Times Cited: 23
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
Berta Soldevila, Manel Puig‐Domingo, Mónica Marazuela
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 2, pp. 137-150
Open Access | Times Cited: 22
A pilot study on the melatonin treatment in patients with early septic shock: results of a single-center randomized controlled trial
Abbas Taher, Farnaz Shokoohmand, Elham Abdoli, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 4, pp. 1913-1924
Open Access | Times Cited: 21
Perioperative melatonin in COVID-19 patients
Abhijit Nair
Medical Gas Research (2022) Vol. 12, Iss. 2, pp. 41-43
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top